Manufacturing / Biological Products, Except Diagnostic Substances
Sana Biotechnology, Inc.
SANA
$4.09
+$0.32 (+8.49%)
Price as of Aug 25, 2026 15:47 UTC
1.1 B
Market Cap (Small Cap)
29%
IV Rank
111.9%
Implied Volatility
Nov 04
Next Earnings
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
0.00
Bullish skew
Implied Volatility
111.9%
0% percentile
IV vs Realized
Options rich
30d HV 58.6%
Options Heat Map
Delta-risk grid for SANA options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
0 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| Jul 06, 2026 | Bishop Hans Edgar | Grant | 6,297 | $0 | |
| Jun 04, 2026 | NELSEN ROBERT | Other | 90,000 | $0 | |
| Jun 04, 2026 | Yang Patrick Y | Other | 90,000 | $0 | |
| Jun 04, 2026 | Mulligan Richard | Other | 90,000 | $0 | |
| Jun 04, 2026 | Bishop Hans Edgar | Other | 90,000 | $0 | |
| Jun 04, 2026 | Bilenker Joshua H. | Other | 90,000 | $0 | |
| Jun 04, 2026 | Rosiello Robert L. | Other | 90,000 | $0 | |
| Jun 04, 2026 | REICIN ALISE | Other | 90,000 | $0 | |
| Jun 04, 2026 | Seitz Michelle | Grant | 90,000 | $0 | |
| Jun 04, 2026 | REICIN ALISE | Grant | 90,000 | $0 |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 10, 2026 | Q2 2026 | -$0.15 | |||
| Jul 30, 2026 | Q2 2026 | -$0.15 | |||
| Jun 30, 2026 | Q2 2026 | -$0.15 | -$0.13 | +12.6% | Beat |
| Mar 31, 2026 | Q1 2026 | -$0.17 | -$0.17 | +1.7% | Beat |
| Dec 31, 2025 | Q4 2025 | -$0.14 | -$0.21 | -55.0% | Miss |
| Sep 30, 2025 | Q3 2025 | -$0.18 | -$0.16 | +12.8% | Beat |
| Jun 30, 2025 | Q2 2025 | -$0.21 | -$0.21 | +0.5% | Beat |
Track SANA with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for SANA and your entire portfolio.